Remix Therapeutics

0 followers


Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.

Employees

11-50

Links

Org chart

Peter Smith
Co-Founder, & CEO

Peter Smith

Collapse
Heather Wasserman
COO & Chief Business Officer
Silvia Buonamici
SVP, in silico & in vivo Biosciences
Cecile Blaustein
VP, Program Management
Mark Scuzzarella
VP, Human Resources
Matthew Schnaderbeck
Sr. Director, CMC
Dominic Reynolds
SVP, Chemistry